Patents Assigned to The University of Dundee
-
Patent number: 11709160Abstract: A skin sample culture apparatus which has a base frame, with a skin sample receiving surface upon which at least part of the skin sample may be placed and which extends across an area defined by the shape of the frame. A securing member which is releasably connectable to the base frame and a grip which holds the skin sample under tension. The apparatus may include a tensioner to hold the sample under tension and means for introducing a fluid to the upper or lower surface of the sample.Type: GrantFiled: May 22, 2017Date of Patent: July 25, 2023Assignee: The University of DundeeInventors: Robyn Patricia Hickerson, Michael John Conneely
-
Patent number: 10065965Abstract: A compound of Formula (I), or a salt thereof, compositions comprising the compound, processes for its preparation and its use in therapy, for example in the treatment of parasitic diseases such as Chagas disease, Human African Trypanosomiasis (HAT) and leishmaniasis, particularly visceral leishmaniasis (VL).Type: GrantFiled: May 26, 2016Date of Patent: September 4, 2018Assignees: GlaxoSmithKline Intellectual Property Development Limited, The University of DundeeInventors: Stephen Brand, Elisabet Viayna Gaza, Ian Gilbert, Eun Jung Ko, Maria Marco Martin, Timothy James Miles, Lars Henrik Sandberg, Michael George Thomas
-
Patent number: 9944927Abstract: The present invention provides methods and compositions for modulating cell senescence and cell proliferation using isoforms of the p53 tumor suppressor protein. The methods and compositions of the invention find use in inhibiting cancer cell growth or in generating populations of cells for tissue regeneration through the modulation of cell senescence and proliferation.Type: GrantFiled: June 29, 2015Date of Patent: April 17, 2018Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, The University of Dundee, Masaryk Memorial Cancer InstituteInventors: Curtis C. Harris, Kaori Fujita, Izumi Horikawa, Borivoj Vojtesek, Jean-Christophe Bourdon, David P. Lane
-
Publication number: 20170050881Abstract: A method for welding together glass workpieces where one of the workpieces has metal nanoparticles positioned at or near the surface to be welded. The method comprises positioning the workpieces in operative contact at an interface where a weld is to be formed, applying a laser beam to be incident upon the interface wherein energy from the laser beam is absorbed by the nanoparticle bearing workpiece and the energy from the laser beam is transferred to the glass surrounding the metal nanoparticles to heat the glass and to weld the workpieces together.Type: ApplicationFiled: January 27, 2015Publication date: February 23, 2017Applicant: The University of DundeeInventor: Amin Abdolvand
-
Patent number: 9454060Abstract: A mode locked semiconductor disk laser with an output beam having an ultra-short pulse length which provides the incident beam to a non linear microscope. The wavelength of the beam is at or near the action cross section maximum absorption wavelength for creating two photon excited fluorescence of a fluorescent biological marker in a sample. Semiconductor disk lasers combine excellent beam quality and output power, stability while maintaining simplicity and easiness of operation. In addition, these types of lasers are ideally suited for mass production as they are built in wafer-scale technology enabling a high level of integration. Importantly this non expensive, turn-key, compact laser system could be used as a platform to develop portable non-linear bio-imaging devices for clinical studies, facilitating its wide-spread adoption in “real-life” applications.Type: GrantFiled: September 19, 2011Date of Patent: September 27, 2016Assignee: The University of DundeeInventors: Craig Hamilton, Graeme Malcolm, Ursula Keller, Thomas Sudmeyer, Kurt Weingarten, Pablo Loza-Alvarez, Yohan Barbarin, Edik Rafailov
-
Publication number: 20160095823Abstract: The present invention concerns compounds derived from the anaesthetic propofol that are useful as analgesics and methods of using the same. The compounds act as co-activators of strychnine-sensitive glycine receptors and may have greater activity at those glycine receptors than at GABAA.Type: ApplicationFiled: November 24, 2015Publication date: April 7, 2016Applicants: The University of Liverpool, The University of Dundee, Medizinische Hochschule HannoverInventors: Martin Leuwer, Gertrud Haeseler, Jeremy Lambert, Delia Belelli
-
Patent number: 9229939Abstract: A system for arranging searchable items, such as digital images or multimedia icons for presentation on a graphical user interface. The system has an optimizer module which minimizes a cost function for arranging items in a layout space and is applied to one or more predetermined characteristics of the items. The optimizer module also creates a mixture distribution by considering each item as having a spatial distribution in the layout space and controls the entropy of the mixture distribution in order to maximize the extent to which each item occupies a separate position in the layout space. A Renderer module then renders the layouts to generate a display.Type: GrantFiled: January 28, 2010Date of Patent: January 5, 2016Assignee: The University of DundeeInventors: Stephen McKenna, Ruixuan Wang, Annette Ward
-
Patent number: 9101345Abstract: A surgical tissue anchor comprising a plurality of jaws suitable for clamping onto tissue, clamp component(s) operable to bias the jaws in a closed position and attachment structure operable for attachment of the anchor to one or more tethers for retracting the clamped tissue. The one or more tethers are guided to the desired region using a surgical guide.Type: GrantFiled: January 19, 2012Date of Patent: August 11, 2015Assignee: The University of DundeeInventors: Stuart Ian Brown, Stuart Coleman, Alfred Cuschieri, Leslie Kelly, Paul Simon Maher, James Duncan Shaw Martin
-
Patent number: 9068165Abstract: The present invention provides methods and compositions for modulating cell senescence and cell proliferation using isoforms of the p53 tumor suppressor protein. The methods and compositions of the invention find use in inhibiting cancer cell growth or in generating populations of cells for tissue regeneration through the modulation of cell senescence and proliferation.Type: GrantFiled: July 26, 2013Date of Patent: June 30, 2015Assignees: The United States of America as represented by the Secretary of the Department of Health and Human Services, The University of Dundee, Masaryk Memorial Cancer InstituteInventors: Curtis C. Harris, Kaori Fujita, Izumi Horikawa, Borivoj Vojtesek, Jean-Christophe Bourdon, David P. Lane
-
Patent number: 8999635Abstract: The present invention relates to the identification of loss-of-function mutations in the filaggrin gene and their use in diagnosing ichthyosis vulgaris and/or susceptibility to other diseases including atopic dermatitis (eczema), asthma, psoriasis and allergies (including food allergy).Type: GrantFiled: December 15, 2006Date of Patent: April 7, 2015Assignee: University Court of The University of DundeeInventors: William Henry Irwin McLean, Frances Jane Dorothy Smith
-
Patent number: 8961179Abstract: An apparatus and method for mineralising demineralised and hypo-mineralised biological material such as tooth or bone. The apparatus has a probe electrode for receiving a mineralisation agent and a counter electrode. It is also provided with a controller to control the electrical signal provided to the probe such that the extent of mineralisation of the biological material is controlled by modulating or changing the electrical signal provided by the probe based upon the measured output of the circuit formed from the probe, counter electrode and biological material. The electrical output provides a measure of the extent of mineralisation of the biological material which is compared with data from a reference technique which gives 3D structural information on an area of interest in the biological material.Type: GrantFiled: August 18, 2009Date of Patent: February 24, 2015Assignees: The University of Dundee, The University of Abertay, Dundee, The University Court of the University of St. AndrewsInventors: Christopher Longbottom, Joseph Crayston, Nigel Berry Pitts, Dmitri Grinev, Iain Young
-
Patent number: 8603753Abstract: An immunoassay for screening a sample to detect the presence of ?-N-methylamino-L-alanine (BMAA) is disclosed. Antibodies specific for BMAA are disclosed. Antibodies that bind to BMAA on immunoblots are disclosed. Immunoassays and kits to detect the presence of BMAA in a sample by contacting the sample with an antibody that binds to BMAA, and detecting the antibody bound to the sample, are disclosed. Immunoassays and kits for screening for the presence of BMAA in a subject by analyzing a tissue sample obtained from the subject to detect the present of BMAA in the tissue sample, where the presence of BMAA in the tissue sample indicates exposure of the subject to an environmental source of BMAA, are disclosed. Immunoassays and kits for detecting an environmental source of BMAA, by screening an environmental sample to detect the presence of BMAA in the sample, wherein the presence of a detectable amount of BMAA in the sample indicates the sample is an environmental source of BMAA, are disclosed.Type: GrantFiled: July 2, 2009Date of Patent: December 10, 2013Assignees: The Institute for Ethnomedicine, The University of DundeeInventors: Paul Alan Cox, James S. Metcalf, Geoffrey A. Codd
-
Publication number: 20130302892Abstract: The present invention provides methods and compositions for modulating cell senescence and cell proliferation using isoforms of the p53 tumor suppressor protein. The methods and compositions of the invention find use in inhibiting cancer cell growth or in generating populations of cells for tissue regeneration through the modulation of cell senescence and proliferation.Type: ApplicationFiled: July 26, 2013Publication date: November 14, 2013Applicants: The Government of the USA as represented by the Sec. of the Dept. of Health and Human Services, Masaryk Memorial Cancer Institute, The University of DundeeInventors: Curtis C. Harris, Kaori Fujita, Izumi Horikawa, Barivoj Vojtesek, Jean-Christophe Bourdon, David P. Lane
-
Patent number: 8575121Abstract: The present invention provides methods and compositions for modulating cell senescence and cell proliferation using isoforms of the p53 tumor suppressor protein. The methods and compositions of the invention find use in inhibiting cancer cell growth or in generating populations of cells for tissue regeneration through the modulation of cell senescence and proliferation.Type: GrantFiled: October 21, 2008Date of Patent: November 5, 2013Assignees: The United States of America as represented by the Secetary of the Department of Health and Human Services, The University of Dundee, Masaryk Memorial Cancer InstituteInventors: Curtis C. Harris, Kaori Fujita, Izumi Horikawa, Borivoj Vojtesek, Jean-Christophe Bourdon, David P. Lane
-
Patent number: 8507724Abstract: The present invention concerns compounds derived from the anaethetic propofol. The compounds may be useful in the treatment of pain, particularly, but not exclusively, chronic pain and central pain sensitisation.Type: GrantFiled: December 9, 2009Date of Patent: August 13, 2013Assignee: The University of DundeeInventors: Martin Leuwer, Paul O'Neill, Neil Berry, Gertrud Haeseler
-
Patent number: 8374876Abstract: A system and a method for speech generation which assist the speech of those with a disability or a medical condition such as cerebral palsy, motor neurone disease or a dysarthia following a stroke. The system has a user interface having a multiplicity of states each of which correspond to a sound and a selector for making a selection of a state or a combination of states. The system also has a processor for processing the selected state or combination of states and an audio output for outputting the sound or combination of sounds. The sounds associated with the states can be phonemes or phonics and the user interface is typically a manually operable device such as a mouse, trackball, joystick or other device that allows a user to distinguish between states by manipulating the interface to a number of positions.Type: GrantFiled: February 1, 2007Date of Patent: February 12, 2013Assignee: The University of DundeeInventors: Rolf Black, Annula Waller, Eric Abel, Iain Murray, Graham Pullin
-
Publication number: 20120085647Abstract: An apparatus and method for mineralising demineralised and hypo-mineralised biological material such as tooth or bone. The apparatus has a probe electrode for receiving a mineralisation agent and a counter electrode. It is also provided with a controller to control the electrical signal provided to the probe such that the extent of mineralisation of the biological material is controlled by modulating or changing the electrical signal provided by the probe based upon the measured output of the circuit formed from the probe, counter electrode and biological material. The electrical output provides a measure of the extent of mineralisation of the biological material which is compared with data from a reference technique which gives 3D structural information on an area of interest in the biological material.Type: ApplicationFiled: August 18, 2009Publication date: April 12, 2012Applicants: The University of Dundee, The University Court of the University of St. Andrews, The University of Abertay DundeeInventors: Christopher Longbottom, Joseph Crayston, Nigel Berry Pitts, Dmitri Grinev, Iain Young
-
Publication number: 20100303925Abstract: The disclosure concerns cosmetic and therapeutic treatment of tissue, such as tooth, to effect, for instance, whitening and tissue re-building through mineralisation and including kits for use in the methods.Type: ApplicationFiled: April 21, 2009Publication date: December 2, 2010Applicants: The University of Dundee, The University of Abertay, University Court of the University of Saint AndrewsInventors: Nigel Pitts, Christopher Longbottom, Joseph Crayston, Dmitri Grinev, Ian McEwing Young
-
Patent number: 7727950Abstract: A kit of parts comprising two or more protein kinase substrate polypeptides, each said substrate polypeptide comprising a specificity conferring portion (which is different for each said kinase substrate polypeptide) and a phosphorylatable portion, wherein the phosphorylatable portions of each polypeptide are capable of being bound in a phosphorylation state-sensitive manner by the same specific binding partner, for example and antibody preparation, and wherein the said specific binding partner is not an antibody specific for phosphotyrosine, phosphoserine or phosphothreonine. The phosphorylatable portion preferably comprises the amino acid sequence LSFAEPG.Type: GrantFiled: March 26, 2003Date of Patent: June 1, 2010Assignee: The University of DundeeInventors: Chris Armstrong, Philip Cohen
-
Publication number: 20090313024Abstract: A system and a method for speech generation which assist the speech of those with a disability or a medical condition such as cerebral palsy, motor neurone disease or a dysarthia following a stroke. The system has a user interface having a multiplicity of states each of which correspond to a sound and a selector for making a selection of a state or a combination of states. The system also has a processor for processing the selected state or combination of states and an audio output for outputting the sound or combination of sounds. The sounds associated with the states can be phonemes or phonics and the user interface is typically a manually operable device such as a mouse, trackball, joystick or other device that allows a user to distinguish between states by manipulating the interface to a number of positions.Type: ApplicationFiled: February 1, 2007Publication date: December 17, 2009Applicant: The University of DundeeInventors: Rolf Black, Annula Waller, Eric Abel, Iain Murray, Graham Pullin